BRPI0517410B1 - Fórmula para bebês contendo beta-soro e seu uso - Google Patents
Fórmula para bebês contendo beta-soro e seu uso Download PDFInfo
- Publication number
- BRPI0517410B1 BRPI0517410B1 BRPI0517410-4A BRPI0517410A BRPI0517410B1 BR PI0517410 B1 BRPI0517410 B1 BR PI0517410B1 BR PI0517410 A BRPI0517410 A BR PI0517410A BR PI0517410 B1 BRPI0517410 B1 BR PI0517410B1
- Authority
- BR
- Brazil
- Prior art keywords
- lactose
- beta
- serum
- powder
- baby formula
- Prior art date
Links
- 235000013350 formula milk Nutrition 0.000 title claims description 79
- 210000002966 serum Anatomy 0.000 title description 6
- 239000008101 lactose Substances 0.000 claims description 121
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 116
- 239000000843 powder Substances 0.000 claims description 83
- 102000004169 proteins and genes Human genes 0.000 claims description 66
- 108090000623 proteins and genes Proteins 0.000 claims description 66
- 235000018102 proteins Nutrition 0.000 claims description 65
- 108010046377 Whey Proteins Proteins 0.000 claims description 28
- 235000021119 whey protein Nutrition 0.000 claims description 23
- 102000007544 Whey Proteins Human genes 0.000 claims description 21
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 16
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 14
- 239000012141 concentrate Substances 0.000 claims description 14
- 235000020183 skimmed milk Nutrition 0.000 claims description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 12
- 239000008158 vegetable oil Substances 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 239000000787 lecithin Substances 0.000 claims description 10
- 229940067606 lecithin Drugs 0.000 claims description 10
- 235000010445 lecithin Nutrition 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 235000014121 butter Nutrition 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 9
- 239000011707 mineral Substances 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 8
- 238000011161 development Methods 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000000968 intestinal effect Effects 0.000 claims description 4
- 206010020751 Hypersensitivity Diseases 0.000 claims description 3
- 230000007815 allergy Effects 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 230000035800 maturation Effects 0.000 claims description 3
- 230000003988 neural development Effects 0.000 claims description 3
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 230000036737 immune function Effects 0.000 claims description 2
- 210000000987 immune system Anatomy 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000009928 pasteurization Methods 0.000 claims 2
- 238000005498 polishing Methods 0.000 claims 2
- 238000000926 separation method Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 238000009489 vacuum treatment Methods 0.000 claims 1
- 239000002351 wastewater Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 description 94
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 92
- 238000000605 extraction Methods 0.000 description 67
- 229940067631 phospholipid Drugs 0.000 description 62
- 150000003904 phospholipids Chemical class 0.000 description 60
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 56
- 239000000047 product Substances 0.000 description 55
- 235000019197 fats Nutrition 0.000 description 52
- 235000013365 dairy product Nutrition 0.000 description 36
- 230000007935 neutral effect Effects 0.000 description 31
- 229910002092 carbon dioxide Inorganic materials 0.000 description 28
- 238000000034 method Methods 0.000 description 27
- 239000000203 mixture Substances 0.000 description 27
- 150000002270 gangliosides Chemical class 0.000 description 22
- 230000008569 process Effects 0.000 description 21
- 235000020256 human milk Nutrition 0.000 description 20
- 210000004251 human milk Anatomy 0.000 description 20
- 239000001569 carbon dioxide Substances 0.000 description 18
- 239000000284 extract Substances 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 239000002956 ash Substances 0.000 description 17
- 239000007787 solid Substances 0.000 description 16
- 239000007858 starting material Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 13
- 235000015155 buttermilk Nutrition 0.000 description 12
- 239000005862 Whey Substances 0.000 description 11
- 235000016709 nutrition Nutrition 0.000 description 9
- -1 phosphorus lipid Chemical class 0.000 description 9
- 238000000108 ultra-filtration Methods 0.000 description 9
- 238000004925 denaturation Methods 0.000 description 8
- 230000036425 denaturation Effects 0.000 description 8
- 230000035764 nutrition Effects 0.000 description 8
- 229930186217 Glycolipid Natural products 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 229940106189 ceramide Drugs 0.000 description 6
- 150000001783 ceramides Chemical class 0.000 description 6
- PFJKOHUKELZMLE-VEUXDRLPSA-N ganglioside GM3 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 PFJKOHUKELZMLE-VEUXDRLPSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 5
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 5
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 235000021243 milk fat Nutrition 0.000 description 5
- 235000015927 pasta Nutrition 0.000 description 5
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 150000003408 sphingolipids Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- 229930183167 cerebroside Natural products 0.000 description 4
- 150000001784 cerebrosides Chemical class 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 108010071421 milk fat globule Proteins 0.000 description 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
- 150000003905 phosphatidylinositols Chemical class 0.000 description 4
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WPIHMWBQRSAMDE-YCZTVTEBSA-N beta-D-galactosyl-(1->4)-beta-D-galactosyl-N-(pentacosanoyl)sphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC WPIHMWBQRSAMDE-YCZTVTEBSA-N 0.000 description 3
- 238000011026 diafiltration Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000019624 protein content Nutrition 0.000 description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 235000014268 sports nutrition Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- 238000004679 31P NMR spectroscopy Methods 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101710191666 Lactadherin Proteins 0.000 description 1
- 102100039648 Lactadherin Human genes 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000019740 Vitamins/micromineral premix Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- QUWBSOKSBWAQER-UHFFFAOYSA-N [C].O=C=O Chemical compound [C].O=C=O QUWBSOKSBWAQER-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- MGWWWSRHCOVLIU-UHFFFAOYSA-N benzene-1,3-diol;hydrochloride Chemical compound Cl.OC1=CC=CC(O)=C1 MGWWWSRHCOVLIU-UHFFFAOYSA-N 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000020205 cow's milk formula Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- ABCVHPIKBGRCJA-UHFFFAOYSA-N nonyl 8-[(8-heptadecan-9-yloxy-8-oxooctyl)-(2-hydroxyethyl)amino]octanoate Chemical compound OCCN(CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCCCCCCC(=O)OCCCCCCCCC ABCVHPIKBGRCJA-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000020610 powder formula Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C17/00—Buttermilk; Buttermilk preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2240/00—Use or particular additives or ingredients
- A23C2240/05—Milk products enriched with milk fat globule membrane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Water Supply & Treatment (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ53589404 | 2004-10-12 | ||
| NZ535894 | 2004-10-12 | ||
| NZ535920 | 2004-10-13 | ||
| NZ53592004 | 2004-10-13 | ||
| NZ54044505 | 2005-05-31 | ||
| NZ540445 | 2005-05-31 | ||
| PCT/NZ2005/000262 WO2006041316A1 (en) | 2004-10-12 | 2005-10-12 | Beta-serum dairy products, neutral lipid-depleted and/or polar lipid-enriched dairy products, and processes for their production |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0517410A2 BRPI0517410A2 (pt) | 2015-06-30 |
| BRPI0517410A8 BRPI0517410A8 (pt) | 2015-10-27 |
| BRPI0517410B1 true BRPI0517410B1 (pt) | 2018-02-06 |
Family
ID=36148550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0517410-4A BRPI0517410B1 (pt) | 2004-10-12 | 2005-10-12 | Fórmula para bebês contendo beta-soro e seu uso |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8471002B2 (enExample) |
| EP (1) | EP1814399B1 (enExample) |
| JP (1) | JP2008515455A (enExample) |
| KR (1) | KR20070114108A (enExample) |
| CN (2) | CN101090635B (enExample) |
| AU (2) | AU2005294886B2 (enExample) |
| BR (1) | BRPI0517410B1 (enExample) |
| CA (1) | CA2583704C (enExample) |
| DK (1) | DK1814399T3 (enExample) |
| ES (1) | ES2587338T3 (enExample) |
| IN (3) | IN2012DN02665A (enExample) |
| MX (1) | MX2007004343A (enExample) |
| MY (1) | MY157811A (enExample) |
| PL (1) | PL1814399T3 (enExample) |
| TW (1) | TW200628075A (enExample) |
| WO (1) | WO2006041316A1 (enExample) |
| ZA (1) | ZA200702975B (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR057042A1 (es) | 2005-05-31 | 2007-11-14 | Arla Foods Amba | Fracciones de leche enriquecidas con fosfatidilserina para la formulacion de alimentos funcionales |
| NZ547429A (en) * | 2006-05-24 | 2009-09-25 | Ind Res Ltd | Extraction of highly unsaturated lipids with liquid dimethyl ether |
| US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
| EP1880612A1 (fr) | 2006-07-17 | 2008-01-23 | Corman S.A. | Ingrédient laitier enrichi en lipides polaires et applications de celui-ci |
| NZ560524A (en) | 2007-08-09 | 2011-04-29 | Fonterra Co Operative Group | Treating or preventing rotavirus infection using conjugated linoleic acid |
| WO2009051502A1 (en) * | 2007-10-19 | 2009-04-23 | Steven Charles Hodgkinson | Methods of maintaining or increasing growth or cognitive development |
| PT2296494E (pt) * | 2008-06-16 | 2012-06-15 | Nutricia Nv | Fórmula de leite para lactentes com gradiente de matéria gorda |
| US8498729B2 (en) | 2008-08-29 | 2013-07-30 | Smp Logic Systems Llc | Manufacturing execution system for use in manufacturing baby formula |
| EP2163160A1 (en) | 2008-09-05 | 2010-03-17 | Meggle Japan Co., Ltd. | Composition richly containing polar lipid and method of manufacturing the same |
| EP2168438A1 (en) | 2008-09-05 | 2010-03-31 | Meggle Japan Co., Ltd. | Composition richly containing polar lipid and method of manufacturing the same |
| NZ571856A (en) * | 2008-10-09 | 2011-02-25 | Fonterra Corporate Res And Dev Ltd | Use of a phospholipid and ganglioside composition for the treatment or prevention of gout |
| WO2010068086A1 (en) * | 2008-12-11 | 2010-06-17 | N.V. Nutricia | Nutritional compositions with large lipid globule size |
| WO2011028797A2 (en) * | 2009-09-01 | 2011-03-10 | Lazarus Therapeutics, Inc. | Treatment of glaucoma and other retinopathies with gangliosides |
| US9226521B2 (en) | 2009-12-08 | 2016-01-05 | Nestec S.A. | Infant formula with probiotics and milk fat globule membrane components |
| CN102811623B (zh) * | 2010-02-12 | 2014-11-26 | 阿尔拉食品公司 | 替代奶制品 |
| JP2011212611A (ja) * | 2010-03-31 | 2011-10-27 | Snow Brand Milk Products Co Ltd | 乳素材の分離方法 |
| WO2012092086A1 (en) | 2010-12-29 | 2012-07-05 | Abbott Laboratories | Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child |
| US20140199265A1 (en) * | 2013-01-11 | 2014-07-17 | Mead Johnson Nutrition Company | Nutritional compositions containing a neurologic component and uses thereof |
| SG11201507217PA (en) * | 2013-03-13 | 2015-10-29 | Abbott Lab | Method of enhancing bioavailability of dha and other lipid-soluble nutrients |
| HK1219207A1 (zh) * | 2013-03-13 | 2017-03-31 | Abbott Laboratories | 刺激婴儿肺和肠成熟的方法 |
| CN105813475A (zh) * | 2013-12-12 | 2016-07-27 | 雀巢产品技术援助有限公司 | 特别适合于男女婴儿和幼儿的合成营养组合物 |
| CN105813477A (zh) * | 2013-12-12 | 2016-07-27 | 雀巢产品技术援助有限公司 | 用于三个月以下和以上婴儿认知功能健康建立的、包含n-6二十碳三烯酸和极性脂质的合成乳组合物 |
| EP3079499B1 (en) * | 2013-12-12 | 2019-02-20 | Nestec S.A. | Synthetic milk compositions comprising polyunsaturated fatty acids (pufas) for promoting the healthy establishment of cognitive function in male and female infant and children |
| FI129799B (en) | 2017-06-16 | 2022-08-31 | Valio Oy | Buttermilk |
| US11425915B2 (en) | 2018-05-02 | 2022-08-30 | Land O'lakes, Inc. | Methods of concentrating phospholipids |
| WO2019224166A1 (en) * | 2018-05-22 | 2019-11-28 | Societe Des Produits Nestle S.A. | Nutritional composition |
| AU2019291666B2 (en) | 2018-06-22 | 2023-09-21 | Fonterra Co-Operative Group Limited | Use of polar lipids to treat or prevent gestational diabetes mellitus |
| US12161131B2 (en) | 2018-12-20 | 2024-12-10 | Land O'lakes, Inc. | Cheese sauce |
| WO2020168439A1 (en) | 2019-02-22 | 2020-08-27 | Aquero Canada Ltd. | Fortified milk compositions and their processes of preparation |
| CN112205475B (zh) * | 2019-07-10 | 2023-09-01 | 丰益(上海)生物技术研发中心有限公司 | 一种结构化乳液 |
| KR20210069460A (ko) | 2019-12-03 | 2021-06-11 | 솔루스첨단소재 주식회사 | 유청 유래 극성지질 농축 분획 조성물 및 이의 용도 |
| CN112051340A (zh) * | 2020-09-04 | 2020-12-08 | 陕西科技大学 | 一种鲜马乳中乳脂肪球膜的提取及其蛋白质组学分析方法 |
| ES3003732T3 (en) | 2020-11-27 | 2025-03-21 | Arla Foods Amba | Novel cholesterol-enriched milk lipid composition suitable for infant nutrition, method of production, and nutritional compositions comprising the milk lipid composition |
| US20230380445A1 (en) | 2020-12-18 | 2023-11-30 | Solus Biotech Co., Ltd. | Whey-derived polar lipids-concentrated fraction composition and use thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2104367A5 (enExample) * | 1970-08-20 | 1972-04-14 | Chevron Res | |
| JPS609770B2 (ja) | 1977-11-16 | 1985-03-13 | 旭化成株式会社 | 脱コレステロ−ル脱脂卵粉末の製造法 |
| US4157404A (en) | 1978-07-28 | 1979-06-05 | Asahi Kasei Kogyo Kabushiki Kaisha | Process for obtaining yolk lecithin from raw egg yolk |
| GB2087211B (en) | 1980-11-17 | 1984-09-26 | Bratland Arthur | Dairy process |
| RO85044B1 (ro) * | 1982-06-18 | 1984-09-30 | Institutul De Chimie Alimentara | Lapte praf medicamentos pentru combaterea distrofiei la sugari si procedeu pentru obtinerea acestuia |
| US4762822A (en) | 1985-08-08 | 1988-08-09 | Ettinger Anna C | Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides |
| JPS62134042A (ja) * | 1985-12-05 | 1987-06-17 | Riyoushiyoku Kenkyukai | 低コレステロ−ルバタ−脂の分別法 |
| WO1991014377A1 (en) | 1990-03-21 | 1991-10-03 | Portwall Pty Limited | Processing of mixtures containing lipids and proteins and products so produced |
| ES2033193B1 (es) | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
| JP3137268B2 (ja) | 1991-05-20 | 2001-02-19 | 明治乳業株式会社 | 高コレステロ−ル含有乳製品 |
| SE501697C2 (sv) * | 1993-02-11 | 1995-04-24 | Svenska Mejeriernas Riksforeni | Förfarande för utvinning av sfingomyelin |
| JP3213453B2 (ja) * | 1993-09-27 | 2001-10-02 | 明治乳業株式会社 | ホエー中の脂肪球皮膜物質からの塩類の除去方法及び各種成分の分離方法 |
| US5518751A (en) | 1994-09-08 | 1996-05-21 | Friesland Brands B.V. | Process for the preparation of milk concentrates and milk powders having a long storage life |
| US6391362B1 (en) | 1996-08-27 | 2002-05-21 | Ronald C. Gorewit | Bulk preparation of milk fat globule membranes |
| US5993873A (en) | 1997-07-10 | 1999-11-30 | Nestec S.A. | Preparation of a food product powder prepared with components including milk powder and lipids |
| JP3203485B2 (ja) | 1998-08-19 | 2001-08-27 | 明治乳業株式会社 | リン脂質及び脂肪酸組成を調整した乳児用食品組成物 |
| AU3884500A (en) | 1999-03-16 | 2000-10-04 | Martek Biosciences Corporation | Infant formulas and other food products containing phospholipids |
| JP3544493B2 (ja) | 1999-06-10 | 2004-07-21 | 雪印乳業株式会社 | 乳幼児用栄養組成物 |
| JP3195594B2 (ja) | 1999-11-02 | 2001-08-06 | 明治乳業株式会社 | 乳由来のリン脂質を配合した食品組成物。 |
| AU1769001A (en) | 1999-11-16 | 2001-05-30 | Ronald C. Gorewit | Bulk preparation of milk fat globule membranes |
| WO2002034062A1 (en) | 2000-10-27 | 2002-05-02 | Nv Marc Boone | Method for obtaining products enriched in phospho- and sphingolipids |
| JP2003003192A (ja) | 2001-06-20 | 2003-01-08 | Unitika Ltd | スフィンゴ脂質又はスフィンゴ糖脂質の抽出方法 |
| AU2002330968B2 (en) | 2001-08-17 | 2007-03-22 | Neose Technologies, Inc. | Chemo-enzymatic synthesis of sialylated oligosaccharides |
| JP2003235462A (ja) | 2002-02-08 | 2003-08-26 | Asahi Denka Kogyo Kk | 乳化活性物質及び水中油型乳化脂 |
| JP3623944B2 (ja) | 2002-04-17 | 2005-02-23 | 株式会社ファンケル | ホスファチジルセリン高含有組成物 |
| IL150240A (en) | 2002-06-16 | 2005-07-25 | Lipogen Ltd | Infant formula supplemented with phospholipids |
| CN1489914A (zh) * | 2002-10-18 | 2004-04-21 | 内蒙古蒙牛乳业（集团）股份有限公司 | 一种适用于婴儿食用的液体奶 |
| JP4314025B2 (ja) | 2002-12-10 | 2009-08-12 | 明治乳業株式会社 | 風味の良いバターミルク関連乳製品、乳加工品の製造法 |
| NZ523920A (en) | 2003-01-31 | 2005-11-25 | Fonterra Co Operative Group | Methods for extracting lipids from diary products using a near critical phase fluid |
| JPWO2004080475A1 (ja) | 2003-03-14 | 2006-06-08 | 明治乳業株式会社 | 抗ロタウィルス感染組成物、およびその製法 |
| US7867541B2 (en) | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
| AR057042A1 (es) | 2005-05-31 | 2007-11-14 | Arla Foods Amba | Fracciones de leche enriquecidas con fosfatidilserina para la formulacion de alimentos funcionales |
| US20060275333A1 (en) | 2005-06-03 | 2006-12-07 | Humco Holding Group, Inc. | Composition with beads for treatment of contact dermatitis |
-
2005
- 2005-10-12 CN CN2005800406692A patent/CN101090635B/zh not_active Ceased
- 2005-10-12 JP JP2007536638A patent/JP2008515455A/ja active Pending
- 2005-10-12 KR KR1020077010178A patent/KR20070114108A/ko not_active Withdrawn
- 2005-10-12 PL PL05801035T patent/PL1814399T3/pl unknown
- 2005-10-12 DK DK05801035.6T patent/DK1814399T3/en active
- 2005-10-12 CN CN2012102773414A patent/CN103120222A/zh active Pending
- 2005-10-12 IN IN2665DEN2012 patent/IN2012DN02665A/en unknown
- 2005-10-12 CA CA2583704A patent/CA2583704C/en not_active Expired - Fee Related
- 2005-10-12 WO PCT/NZ2005/000262 patent/WO2006041316A1/en not_active Ceased
- 2005-10-12 AU AU2005294886A patent/AU2005294886B2/en not_active Ceased
- 2005-10-12 US US11/577,190 patent/US8471002B2/en active Active
- 2005-10-12 IN IN2663DEN2012 patent/IN2012DN02663A/en unknown
- 2005-10-12 BR BRPI0517410-4A patent/BRPI0517410B1/pt not_active IP Right Cessation
- 2005-10-12 TW TW094135780A patent/TW200628075A/zh unknown
- 2005-10-12 IN IN2664DEN2012 patent/IN2012DN02664A/en unknown
- 2005-10-12 MX MX2007004343A patent/MX2007004343A/es active IP Right Grant
- 2005-10-12 MY MYPI20054803A patent/MY157811A/en unknown
- 2005-10-12 ES ES05801035.6T patent/ES2587338T3/es not_active Expired - Lifetime
- 2005-10-12 EP EP05801035.6A patent/EP1814399B1/en not_active Revoked
-
2007
- 2007-04-11 ZA ZA2007/02975A patent/ZA200702975B/en unknown
-
2010
- 2010-12-17 AU AU2010257271A patent/AU2010257271B8/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005294886A1 (en) | 2006-04-20 |
| WO2006041316A1 (en) | 2006-04-20 |
| JP2008515455A (ja) | 2008-05-15 |
| IN2012DN02665A (enExample) | 2015-09-11 |
| TW200628075A (en) | 2006-08-16 |
| CA2583704C (en) | 2012-12-11 |
| US20080139499A1 (en) | 2008-06-12 |
| IN2012DN02663A (enExample) | 2015-09-11 |
| ES2587338T3 (es) | 2016-10-24 |
| MY157811A (en) | 2016-07-29 |
| IN2012DN02664A (enExample) | 2015-09-11 |
| KR20070114108A (ko) | 2007-11-29 |
| AU2010257271B8 (en) | 2013-03-14 |
| MX2007004343A (es) | 2007-09-25 |
| PL1814399T3 (pl) | 2017-07-31 |
| CN101090635A (zh) | 2007-12-19 |
| ZA200702975B (en) | 2009-12-30 |
| AU2005294886B2 (en) | 2010-11-04 |
| CN103120222A (zh) | 2013-05-29 |
| EP1814399A1 (en) | 2007-08-08 |
| BRPI0517410A2 (pt) | 2015-06-30 |
| EP1814399A4 (en) | 2011-03-23 |
| AU2010257271B2 (en) | 2012-11-15 |
| CN101090635B (zh) | 2012-10-03 |
| DK1814399T3 (en) | 2016-09-05 |
| BRPI0517410A8 (pt) | 2015-10-27 |
| CA2583704A1 (en) | 2006-04-20 |
| US8471002B2 (en) | 2013-06-25 |
| EP1814399B1 (en) | 2016-05-18 |
| AU2010257271A1 (en) | 2011-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0517410B1 (pt) | Fórmula para bebês contendo beta-soro e seu uso | |
| US8231922B2 (en) | Phosphatidylserine enriched milk fractions for the formulation of functional foods | |
| US9700061B2 (en) | Milk ingredient enriched in polar lipids and uses thereof | |
| EP2592938B2 (en) | Dairy product and process | |
| CN107259527A (zh) | 营养组合物 | |
| JP2001128642A (ja) | 乳由来のリン脂質を配合した食品組成物。 | |
| EP4030921B1 (en) | Whey-based nutritional compositions fortified with calcium | |
| RU2417614C2 (ru) | Детское питание с бета-сывороткой | |
| Hebatallah et al. | Buttermilk: one of the oldest functional foods | |
| EP4057841B1 (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| NZ556699A (en) | Dairy product and process | |
| NZ589996A (en) | Dairy product and process | |
| NZ579681A (en) | Process of extracting dried beta-serum with near critical carbon dioxide | |
| CN101472480B (zh) | 包含中枢神经系统脂质的乳基食品 | |
| WO2022078679A1 (en) | Nutritional composition | |
| HK1107913A (en) | β-SERUM DAIRY PRODUCTS, NEUTRAL LIPID-DEPLETED AND/OR POLAR LIPID-ENRICHED DAIRY PRODUCTS, AND PROCESSES FOR THEIR PRODUCTION | |
| WO2025252873A1 (en) | Use of a composition comprising a phospholipid-enriched milk fraction and spc in the prevention of an infection with rsv | |
| HK40081708B (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| HK40081708A (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: APRESENTE NOVO DOCUMENTO DE CESSAO DOS DEPOSITANTES "OWEN CATCHPOLE" E "JOHN BERTRAM GREY" COM DATA ANTERIOR A DATA DE ENTRADA NA FASE NACIONAL (12/04/2007) OU APRESENTE DOCUMENTO DEVIDAMENTE RECONHECIDO PELO ESCRITORIO INTERNACIONAL (OMPI) INDICANDO A CESSAO DOS REFERENTES DEPOSITANTES, UMA VEZ QUE O DOCUMENTO DE CESSAO APRESENTADO ATRAVES DA PETICAO NO 020070178751/RJ DE 17/12/2007, POSSUI DATA POSTERIOR A DATA DE ENTRADA NA FASE NACIONAL DO REFERIDO PEDIDO. |
|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: A DEPOSITANTE. DESPACHO: CUMPRIR A EXIGENCIA FORMULADA NO PRAZO DE 60 (SESSENTA) DIAS CONTADO DESSA NOTIFICACAO. A FOTOCOPIA DO TEXTO DO DESPACHO DE EXIGENCIA PODERA SER SOLICITADA ATRAVES DO FORMULARIO MODELO 1.05. |
|
| B15V | Prolongation of time limit allowed |
Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 22 DIAS, CORRESPONDENTE AO PERIODO ENTRE 27/02/2012, QUANDO A FOTOCOPIA FOI SOLICITADA, E 20/03/2012, QUANDO A MESMA FOI DISPONIBILIZADA PARA O USUARIO, PARA QUE SEJA APRESENTADO O CUMPRIMENTO DE EXIGENCIA. |
|
| B25A | Requested transfer of rights approved |
Owner name: FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) |
|
| B15G | Petition not considered as such [chapter 15.7 patent gazette] |
Free format text: A PETICAO DE NO 20120075055/RJ DE 10/08/2012, E CONSIDERADA COMO PETICAO NAO CONHECIDA EM VIRTUDE DO SERVICO SOLICITADO PELA MESMA JA TER SIDO ATENDIDO NA RPI 2338 ATRAVES DA PETICAO 20080138907 DE 05/11/2008. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2796 DE 06-08-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |